Historique
Brochure
Early-warning system on new synthetic drugs: guidance on implementation
(Système d'alerte rapide sur les drogues ssynthétiques : guide de mise en oeuvre)
Année
2002
Page(s) :
39 p.
Sous-type de document :
Guide pratique / Manual
Langue(s) :
Anglais
Éditeur(s) :
Lisbon : OEDT / EMCDDA
;
Luxembourg : Office for Official Publications of the European Communities
Collection :
Risk assessments
Domaine :
Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Note générale :
The EWS guidelines have been fully redrafted in order to reflect the scope and deadlines stipulated by Council Decision 2005/387/JHA, thus replacing these guidelines. Please see "Early-warning system on new psychoactive substances - operating guidelines", 2007.
Résumé :
ENGLISH :
Within the framework of the joint Action of 16 June 1997, the Early-warning System (EWS) aims to create a mechanism for the rapid exchange of information on the production, traffic, use and risks of new synthetic drugs. Taking into account the experience acquired by all actors involved since the adoption of the Joint Action, some guidance is presented here to contribute to improving the functioning of the EWS. This has been put together by analysing the main elements of the system and identifying the developments needed. This document should be regarded as a practical booklet on how the EWS functions and it will continue to be modified in the future in light of new experience and additional knowledge. Within the framework of the EMCDDA's tasks of preparing for the enlargement process, it has been considered useful to publish this booklet so as to help the candidate countries to enhance their knowledge of the joint Action, and especially on the challenges of setting up an EWS on new synthetic drugs.
Within the framework of the joint Action of 16 June 1997, the Early-warning System (EWS) aims to create a mechanism for the rapid exchange of information on the production, traffic, use and risks of new synthetic drugs. Taking into account the experience acquired by all actors involved since the adoption of the Joint Action, some guidance is presented here to contribute to improving the functioning of the EWS. This has been put together by analysing the main elements of the system and identifying the developments needed. This document should be regarded as a practical booklet on how the EWS functions and it will continue to be modified in the future in light of new experience and additional knowledge. Within the framework of the EMCDDA's tasks of preparing for the enlargement process, it has been considered useful to publish this booklet so as to help the candidate countries to enhance their knowledge of the joint Action, and especially on the challenges of setting up an EWS on new synthetic drugs.
Affiliation :
Portugal